Bioprocessing - Upstream & Downstream

Who deserves a place on our annual list of inspirational and influential industry professionals?

An expert from Samsung Biologics offers her perspective on the future of antibody drug conjugates.

NervGen President and CEO Mike Kelly discusses the potential of the company’s investigational drug NVG-291 for spinal cord injury.

How metabolic conditioning could improve cell therapy potency and persistence.

Cryogenic freezing performed too fast can damage biopharma products. What’s the best way forward? An expert gives their view.

Progress in Alzheimer’s Disease research, but a cure will take time. Delaying it and disseminating that research may buy scientists the time they need

Biopharma tech continues to advance so why is downstream processing such a headache?

Lipid nanoparticles are a cornerstone of mRNA therapeutics. For manufacturing, will you choose stainless steel or single-use?

Looking at key milestones, challenges, and innovations in cell culture media – and what lies in store ahead.

CRISPR tech in antibody manufacturing, sterilization of single-use systems, and more! Check out our eBook.